Nemera breaks ground in Brazil through Milfra acquisition
June 17, 2021Read moreNemera breaks ground in Brazil through Milfra acquisition With this acquisition Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America. Nemera today announced that they have entered into an agreement to acquire Milfra. Milfra, based in Jaguariuna, state of São Paulo, Brazil, specializes in the development
How to correctly use a nasal spray?
June 17, 2021Read moreNemera collaborated with several ENT specialists to work on the recommendations on the correct steps to use a nasal spray for patient education therapy.
The added value of a platform approach: pen injector case study
June 7, 2021Read moreThe latest issue of ‘Injectable Drug Delivery’ is highlighted our experts discussion about developing Nemera’s pen-injector platform to reach customer needs
Integrated turnkey solutions: key to successful nasal combination product development
June 4, 2021Read moreThe latest issue of ‘Nasal & Pulmonary Drug Delivery’ is highlighted our experts discussion about developing complex nasal devices helped by Nemera experience.
Patient Journey as a key to develop Inhalation combination products
May 12, 2021Read moreThe latest issue of ‘Pharma Technology’ is highlighted our experts point of view about developing adapted inhalation device for a better patient’s adherence.
